Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays the clinical trial record for ABBV-399, including its study design, eligibility criteria, treatments, outcomes, locations, and record dates.SummaryDifference79%

- Check19 days agoChange DetectedThe footer now identifies a newer ClinicalTrials.gov site revision, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide NIH announcement banner links to transition updates and says that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check53 days agoChange DetectedRemoval of the 403 Forbidden HTML block and Home link indicates the previous access error is resolved and the page is positioned to display its standard content.SummaryDifference0.5%

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.